Next Article in Journal
Minimal Residual Disease in Multiple Myeloma—Current Approaches and Future Clinical Implications
Next Article in Special Issue
Evolution in the Definition of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: A Model for the Future of Personalized Medicine
Previous Article in Journal
Role of PPAR Receptor and Ligands in the Pathogenesis and Therapy of Hematologic Malignancies
Previous Article in Special Issue
Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features
 
 
Article

Article Versions Notes

Hemato 2022, 3(3), 434-453; https://doi.org/10.3390/hemato3030030
Action Date Notes Link
article pdf uploaded. 13 July 2022 15:09 CEST Version of Record https://www.mdpi.com/2673-6357/3/3/30/pdf-vor
article supplementary file uploaded. 13 July 2022 15:09 CEST - https://www.mdpi.com/2673-6357/3/3/30#supplementary
article xml file uploaded 14 July 2022 05:39 CEST Original file -
article xml uploaded. 14 July 2022 05:39 CEST Update https://www.mdpi.com/2673-6357/3/3/30/xml
article pdf uploaded. 14 July 2022 05:39 CEST Updated version of record https://www.mdpi.com/2673-6357/3/3/30/pdf
article html file updated 14 July 2022 05:40 CEST Original file -
article html file updated 13 August 2022 01:36 CEST Update https://www.mdpi.com/2673-6357/3/3/30/html
Back to TopTop